Carrick Therapeutics Limited

This study tested a new drug called CT7001, alone or with other cancer treatments, in 124 people with advanced solid tumors like breast and prostate cancer. The main goal was to check safety and side effects. The drug is taken by mouth, and the study looked at how it works in dif…

This study tested a new combination of two drugs, samuraciclib and elacestrant, in 49 adults with a type of advanced breast cancer (HR+/HER2-). The goal was to find the right dose and see if the combination is safe and can slow cancer growth. Participants had already tried other …

This study tested whether adding the experimental drug samuraciclib to the standard hormone therapy fulvestrant works better than fulvestrant alone. It involved 60 adults with a common type of advanced breast cancer (HR+/HER2-) that had worsened after prior treatment. The goal wa…